Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries

Overview of attention for article published in Frontiers in Pharmacology, June 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news: 1 news outlet
policy: 1 policy source

twitter: 4 X users

Citations

dimensions_citation: 9 Dimensions

Readers on

mendeley: 34 Mendeley

Summary News Policy documents X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 8,498 followers.

RT @cpontesg: 📥 Just published: European overview of available utilization & outcome data for oncological drugs in 18 countries, and oppor…

17 Jun 2022

Reply Repost Favourite

RT @cpontesg: 📥 Just published: European overview of available utilization & outcome data for oncological drugs in 18 countries, and oppor…

17 Jun 2022

Reply Repost Favourite

📥 Just published: European overview of available utilization & outcome data for oncological drugs in 18 countries, and opportunities for collaboration. @DS3cat @karolinskainst https://t.co/XY76Ypw0vw

17 Jun 2022

Reply Repost Favourite

New Research: Challenges and Opportunities With Routinely Collected Data on the Utilization of Cancer Medicines. Perspectives From Health Authority Personnel Across 18 European Countries https://t.co/jo3Z49OZ1b #pharmacology

16 Jun 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.